ClinicalTrials.Veeva

Menu

Post-Acute Phase of Cardiogenic Shock

M

Mackay Memorial Hospital

Status

Enrolling

Conditions

Cardiogenic Shock

Study type

Observational

Funder types

Other

Identifiers

NCT07266675
24MMHIS216e

Details and patient eligibility

About

Epidemiology studies showed that the burden of cardiogenic shock (CS) persistently high, with increasing annual medical expenses and steady prevalence. In-hospital and one-year mortality reduce annually. Hence, there are increasing number of patients who survive to hospital discharge but they will face further challenges in the subacute stage after hospital discharge. However, there are still insufficient studies focusing on this issue. Establishment of a healthcare neatwork to help hospital survivors of CS return society safely is critical.

Full description

Multicener, prospective cohort study

Enrollment

350 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Hospital survivors of cardiogenic shock

Exclusion criteria

  • Age < 18 years。
  • Patient or family refuse follow-up.
  • Patient died within hospital stay.

Trial contacts and locations

1

Loading...

Central trial contact

Shih-Chieh Chien, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems